Clinical Trial Update: Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled, dose-escalation trial in subjects with Type 2 Diabetes Mellitus treated with sulfonylurea has been completed, sponsored by Ionis P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED